Rain Therapeutics (RAIN) has released an update to notify the public and investors about a material modification to rights of security holders.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The current report consolidates details from several sections, including completed corporate events, changes to rights of security holders, director and executive officer changes, and amendments to the company’s code of ethics and bylaws, into a singular section for streamlined reference.
For further insights into RAIN stock, check out TipRanks’ Stock Analysis page.
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue